Thursday, August 04, 2022 8:39:03 AM
ILIM merger closes this week, on or before August 5, 2022. All due diligence items have been completed and the final acquisition documents have been signed. All acquisition formalities bookkeeping items associated with the transfer of shares have been completed and our CEO’s holding has been finalized on the company's official shareholder records. Two classes of shares were used for the transaction: (a) the 2022 Series A Preferred (non-participatory and non-convertible), and (b) Five (5) billion shares of the Company’s common stock which are under LOCK-UP for two years. The shares used would not increase the float for a minimum of two years. After the expiration of the two year lock-up, traditional control-restriction would apply to the five (5) billion shares. The consolidated firm could run as a “holdco” or as a “joint-venture” wherein portfolio/acquired business operations go into the vehicle best suited for it based on management’s best judgment. All conditions precedent has been met and no material item is outstanding.
The deal is valued at $51.8 million based Aamani Healthcare Group has 2021 annual net income of $2.25 million, on Revenue of $6.08 million, leveraging as assets base of $11.96 million. The transaction multiple was based on industry 23, which in this particular industry was conservative considering the ILIM planned rollup and acquisitions.
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Warren Buffett
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM